education · health · HHS-NIH11

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

National Institutes of Health · PAR-25-081

134 days left

Award Range

$0 – $499.999K

Total Program Funding

$499.999K

Deadline

January 7, 2027

GRANTQUICK SUMMARYPlain-English Overview

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required). National Institutes of Health. Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research... up to $499,999 per award; $499,999 total program funding.

Who Should Apply

For-profit organizations, Other Native American Tribal Organizations, County governments, City/township governments, Nonprofits (non-501c3) (+10 more)

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

•Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Is...
•Deadline: 2027-01-07

💡 GrantQuick Tip

Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.

Competitiveness: Moderate to high — federal grants are always competitive

What This Grant Funds

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

Attachments

PDF

PAR-25-081 Full Announcement Text

PAR-25-081-Full-Announcement.html

Who Can Apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Eligible Applicant Types

For-Profit OrganizationsOther Tribal OrganizationsCounty GovernmentsCity/Township GovernmentsNonprofits without 501(c)(3)State Governments501(c)(3) NonprofitsOther (see NOFO for details)Independent School DistrictsSpecial District GovernmentsPublic And Indian Housing AuthoritiesPublic Colleges & UniversitiesPrivate Colleges & UniversitiesFederally Recognized Tribal GovernmentsSmall Businesses

Funding Details

Maximum Award: $499.999K
Total Program Funding: $499.999K
Cost Sharing Required?: No
Funding Instrument: grant

Key Dates

Posted: November 12, 2024

Application Deadline: January 7, 2027 (134 days remaining)

Agency Contact

NIH Grants Information grantsinfo@nih.gov

grantsinfo@nih.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov

View on Grants.gov